FDA Approved: XOLREMDI — Original Application (X4 Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Xolremdi (mavorixafor) via original NDA from X4 Pharmaceuticals for the treatment of WHIM syndrome, marking the first approved therapy for this rar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Whim Syndrome

Drugs mentioned

• XOLREMDI (mavorixafor)

Snippet

ORIG AP for XOLREMDI (MAVORIXAFOR)